The clinical prior authorization (PA) program assists in the monitoring of drugs not on Medicaid's formulary. The program was made to enhance quality and manage drug classes that need more monitoring. The clinical prior authorization program is also used as a means of ensuring that drugs are being prescribed for the right patients and for the right reasons as drug expenditures is being monitored.
